Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes

Nature Genetics

Volumn 43, Issue 12, 2011, Pages 1275-1280

  Lieberman, Tami D ^a   Michel, Jean Baptiste ^a,b   Aingaran, Mythili ^c   Potter Bynoe, Gail ^c   Roux, Damien ^d   Davis Jr , Michael R ^e   Skurnik, David ^d   Leiby, Nicholas ^a   Lipuma, John J ^f,g   Goldberg, Joanna B ^e   McAdam, Alexander J ^c   Priebe, Gregory P ^c,d   Kishony, Roy ^a,h  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^h HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

ADAPTATION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL MEMBRANE; BACTERIAL MUTATION; BACTERIUM ISOLATE; BURKHOLDERIA; BURKHOLDERIA DOLOSA; BURKHOLDERIA INFECTION; CYSTIC FIBROSIS; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC SELECTION; MOLECULAR EVOLUTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ADAPTATION, BIOLOGICAL; ANTI-BACTERIAL AGENTS; BACTEREMIA; BURKHOLDERIA; BURKHOLDERIA INFECTIONS; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; EPIDEMICS; EVOLUTION, MOLECULAR; GENES, BACTERIAL; GENOME, BACTERIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; LIKELIHOOD FUNCTIONS; LIPOPOLYSACCHARIDES; LUNG DISEASES; PHYLOGENY; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; SELECTION, GENETIC; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); BURKHOLDERIA DOLOSA;

EID: 82255186689     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.997     Document Type: Article

References (38)

1. Suerbaum, S. & Josenhans, C. Helicobacter pylori evolution and phenotypic diversification in a changing host. Nat. Rev. Microbiol. 5, 441-452 (2007). (Pubitemid 46780081)
2. Smith, E.E. et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. USA 103, 8487-8492 (2006). (Pubitemid 43838482)
3. Musher, D.M. et al. Emergence of macrolide resistance during treatment of pneumococcal pneumonia. N. Engl. J. Med. 346, 630-631 (2002). (Pubitemid 34438832)
4. Wong, A. & Kassen, R. Parallel evolution and local differentiation in quinolone resistance in Pseudomonas aeruginosa. Microbiology 157, 937-944 (2011).
5. Zdziarski, J. et al. Host imprints on bacterial genomes-rapid divergent evolution in individual patients. PLoS Pathog. 6, e1001078 (2010).
6. Yang, L. et al. Evolutionary dynamics of a bacteria in a human host environment. Proc. Natl. Acad. Sci. USA 108, 7481-7486 (2011).
7. Kennemann, L. et al. Helicobacter pylori genome evolution during human infection. Proc. Natl. Acad. Sci. USA 108, 5033-5038 (2011).
8. Mwangi, M.M. et al. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc. Natl. Acad. Sci. USA 104, 9451-9456 (2007). (Pubitemid 47185800)
9. Harris, S.R. et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science 327, 469-474 (2010).
10. Goodarzi, H., Hottes, A.K. & Tavazoie, S. Global discovery of adaptive mutations. Nat. Methods 6, 581-583 (2009).
11. Pleasance, E.D. et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463, 191-196 (2010).
12. Moxon, E.R., Rainey, P.B., Nowak, M.A. & Lenski, R.E. Adaptive evolution of highly mutable loci in pathogenic bacteria. Curr. Biol. 4, 24-33 (1994).
13. van der Woude, M.W. & Bäumler, A.J. Phase and antigenic variation in bacteria. Clin. Microbiol. Rev. 17, 581-611 (2004). (Pubitemid 38970684)
14. Croucher, N.J. et al. Rapid pneumococcal evolution in response to clinical interventions. Science 331, 430-434 (2011).
15. Holt, K.E. et al. High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi. Nat. Genet. 40, 987-993 (2008).
16. Pallen, M.J. & Wren, B.W. Bacterial pathogenomics. Nature 449, 835-842 (2007). (Pubitemid 47598624)
17. Elena, S.F. & Lenski, R.E. Evolution experiments with microorganisms: the dynamics and genetic bases of adaptation. Nat. Rev. Genet. 4, 457-469 (2003). (Pubitemid 36648145)
18. Woods, R. et al. Tests of parallel molecular evolution in long-term experiment with Escherichia coli. Proc. Natl. Acad. Sci. USA 103, 9107-9112 (2006). (Pubitemid 43902541)
19. Barrick, J.E. et al. Genome evolution and adaptation in a long-term experiment with Escherichia coli. Nature 461, 1243-1247 (2009).
20. Lipuma, J.J. The changing microbial epidemiology in cystic fibrosis. Clin. Microbiol. Rev. 23, 299-323 (2010).
21. Vermis, K. et al. Proposal to accommodate Burkholderia cepacia genomovar VI as Burkholderia dolosa sp. nov. Int. J. Syst. Evol. Microbiol. 54, 689-691 (2004). (Pubitemid 38771765)
22. Lipuma, J.J. Update on the Burkholderia cepacia complex. Curr. Opin. Pulm. Med. 11, 528-533 (2005).
23. LiPuma, J.J., Dasen, S.E., Nielson, D.W., Stern, R.C. & Stull, T.L. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 336, 1094-1096 (1990). (Pubitemid 20368744)
24. Biddick, R., Spilker, T., Martin, A. & LiPuma, J.J. Evidence of transmission of Burkholderia cepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosis. FEMS Microbiol. Lett. 228, 57-62 (2003). (Pubitemid 37377946)
25. Kalish, L.A. et al. Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis. Am. J. Respir. Crit. Care Med. 173, 421-425 (2006). (Pubitemid 43228330)
26. Morelli, G. et al. Microevolution of Helicobacter pylori during prolonged infection of single hosts and within families. PLoS Genet. 6, e1001036 (2010).
27. Sibley, C.D. et al. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc. Natl. Acad. Sci. USA 105, 15070-15075 (2008).
28. Guss, A.M. et al. Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis. ISME J. 5, 20-29 (2011).
29. Mowat, E. et al. Psuedomonas aeruginosa population diversity and turnover in cystic fibrosis infections. Am. J. Respir. Crit. Care Med. 183, 1674-1679 (2011).
30. Wilder, C.N., Allada, G. & Schuster, M. Instantaneous within-patient diversity of Psuedomonas aeruginosa quorum-sensing populations from cystic fibrosis lung infections. Infect. Immun. 77, 5631-5639 (2009).
31. Weigel, L.M., Steward, C.D. & Tenover, F.C. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae. Antimicrob. Agents Chemother. 42, 2661-2667 (1998). (Pubitemid 28462911)
32. Reyna, F., Huesca, M., Gonzalez, V. & Fuchs, L.Y. Salmonella typhimurium gyrA mutations associated with fluoroquinolone resistance. Antimicrob. Agents Chemother. 39, 1621-1623 (1995).
33. Silhavy, T.J., Kahne, D. & Walker, S. The bacterial cell envelope. Cold Spring Harb. Perspect. Biol. 2, a000414 (2010).
34. Vinion-Dubiel, A.D. & Goldberg, J.B. Lipopolysaccharide of Burkholderia cepacia complex. J. Endotoxin Res. 9, 201-213 (2003). (Pubitemid 36874531)
35. Ortega, X. et al. Reconstitution of O-specific lipopolysaccharide expression in Burkholderia cenocepacia strain J2315, which is associated with transmissible infections in patients with cystic fibrosis. J. Bacteriol. 187, 1324-1333 (2005). (Pubitemid 40299457)
36. Crosson, S., McGrath, P.T., Stephens, C., McAdams, H.H. & Shapiro, L. Conserved modular design of an oxygen sensory/signaling network with species-specific output. Proc. Natl. Acad. Sci. USA 102, 8018-8023 (2005). (Pubitemid 40781055)
37. Worlitzsch, D. et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109, 317-325 (2002). (Pubitemid 34141805)
38. Marteyn, B. et al. Modulation of Shigella virulence in response to available oxygen in vivo. Nature 465, 355-358 (2010).